Bharat Kumar Hirji Thakrar

Spread Co Ltd. is a British broker founded in 2006 that offers spread betting, CFDs, FOREX, and other financial services. The private company is based in London, UK. The British company's trading platform includes pro charting at no extra cost.

London Pilsner Ltd. is a full-service drinks and distribution partner that was founded in 1994. The private company is based in London, UK and exports brands to over 21 markets around the world. The British company has an extensive portfolio of own label brands and distributes famous brands worldwide. The company has an unrivaled reach and capability in exporting iconic drinks brands and help brand owners penetrate new and emerging markets.

Valiant Holdings Ltd. is a holding British company that operates subsidiaries engaged in foreign exchange intermediation activities. The private company is based in Middlesex, UK. and has subsidiaries in United Kingdom. The company was founded in 2008.

Lexcross Ltd. is a British management consulting company that provides management consulting services. The private company is based in Northwood Hills, UK and was founded in 2011.

Founded in 2003, Highassets Ltd. is a British real estate company that engages in buying, selling, and leasing properties. Part of Milebank Ltd., the company is based in Northwood Hills, UK.

T. Bro Investment Ltd. is a British company that engages in letting and operating real estate properties. The private company is based in Middlesex, UK.

Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.